Acadian Asset Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-56,273
| Closed | -$131K | – | 1603 |
|
2024
Q4 | $131K | Buy |
+56,273
| New | +$131K | ﹤0.01% | 1321 |
|
2023
Q2 | – | Sell |
-12,192
| Closed | -$22K | – | 1722 |
|
2023
Q1 | $22K | Sell |
12,192
-9,833
| -45% | -$17.7K | ﹤0.01% | 1641 |
|
2022
Q4 | $40K | Buy |
+22,025
| New | +$40K | ﹤0.01% | 1609 |
|
2022
Q3 | – | Sell |
-34,888
| Closed | -$98K | – | 1668 |
|
2022
Q2 | $98K | Buy |
+34,888
| New | +$98K | ﹤0.01% | 1359 |
|
2021
Q4 | – | Sell |
-31,289
| Closed | -$204K | – | 1667 |
|
2021
Q3 | $204K | Buy |
+31,289
| New | +$204K | ﹤0.01% | 1288 |
|
2020
Q4 | – | Sell |
-2,062
| Closed | -$24K | – | 2195 |
|
2020
Q3 | $24K | Sell |
2,062
-2,233
| -52% | -$26K | ﹤0.01% | 2036 |
|
2020
Q2 | $69K | Buy |
+4,295
| New | +$69K | ﹤0.01% | 1819 |
|